Evidence map›Paper›PMID 31581944›Full record

ArticleMicrobial cell factories2019

Engineering Escherichia coli FAB system using synthetic plant genes for the production of long chain fatty acids.

Elias Kassab, Monika Fuchs, Martina Haack, Norbert Mehlmer, Thomas B Brueck

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Genome Mining ofMicroorganisms · 2024
    Article
  2. Article
  3. Review
  4. Proteomic Profiling of Outer Membrane Vesicles Released byJournal of personalized medicine · 2022
    Article
  5. Review
  6. Glucose-Derived Raspberry Ketone Produced via EngineeredFrontiers in bioengineering and biotechnology · 2022
    Article
  7. Review
  8. Review
  9. A kinetic rationale for functional redundancy in fatty acid biosynthesis.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Elias KassabWerner Siemens-Chair of Synthetic Biotechnology, Department of Chemistry, Technical University of Munich, 85748, Garching, Germany.
Monika FuchsWerner Siemens-Chair of Synthetic Biotechnology, Department of Chemistry, Technical University of Munich, 85748, Garching, Germany.
Martina HaackWerner Siemens-Chair of Synthetic Biotechnology, Department of Chemistry, Technical University of Munich, 85748, Garching, Germany.
Norbert MehlmerWerner Siemens-Chair of Synthetic Biotechnology, Department of Chemistry, Technical University of Munich, 85748, Garching, Germany.
Thomas B BrueckWerner Siemens-Chair of Synthetic Biotechnology, Department of Chemistry, Technical University of Munich, 85748, Garching, Germany. brueck@tum.de.ORCID http://orcid.org/0000-0002-2113-6957
Siemens (Germany) · DE

Funding

Bavarian Ministry of Economic Affairs, Energy and Technology (1340/68351/13/2013)German Ministry for Education and Research (BMBF) 031A305AGerman Ministry for Education and Research (BMBF) 033RC012B
6 · The paper itself

Abstract

backgroundSustainable production of microbial fatty acids derivatives has the potential to replace petroleum based equivalents in the chemical, cosmetic and pharmaceutical industry. Most fatty acid sources for production oleochemicals are currently plant derived. However, utilization of these crops are associated with land use change and food competition. Microbial oils could be an alternative source of fatty acids, which circumvents the issue with agricultural competition.

resultsIn this study, we generated a chimeric microbial production system that features aspects of both prokaryotic and eukaryotic fatty acid biosynthetic pathways targeted towards the generation of long chain fatty acids. We redirected the type-II fatty acid biosynthetic pathway of Escherichia coli BL21 (DE3) strain by incorporating two homologues of the beta-ketoacyl-[acyl carrier protein] synthase I and II from the chloroplastic fatty acid biosynthetic pathway of Arabidopsis thaliana. The microbial clones harboring the heterologous pathway yielded 292 mg/g and 220 mg/g DCW for KAS I and KAS II harboring plasmids respectively. Surprisingly, beta-ketoacyl synthases KASI/II isolated from A. thaliana showed compatibility with the FAB pathway in E. coli.

conclusionThe efficiency of the heterologous plant enzymes supersedes the overexpression of the native enzyme in the E. coli production system, which leads to cell death in fabF overexpression and fabB deletion mutants. The utilization of our plasmid based system would allow generation of plant like fatty acids in E. coli and their subsequent chemical or enzymatic conversion to high end oleochemical products.

Indexed as

Metabolic Engineering3-Oxoacyl-(Acyl-Carrier-Protein) SynthaseArabidopsisArabidopsis ProteinsBiosynthetic PathwaysEscherichia coliEscherichia coli ProteinsFatty AcidsFatty Acid SynthasesIsoenzymesPlasmids3-Oxoacyl-(Acyl-Carrier-Protein) SynthaseArabidopsis Proteinsbeta-ketoacyl-acyl carrier protein synthase IEscherichia coli ProteinsFatty AcidsFatty Acid SynthasesIsoenzymesArabidopsis thalianaChloroplastEscherichia coliFatty acid biosynthesisHeterologous expressionLong chain fatty acidsType-II fatty acid synthaseβ-Ketoacyl-[acyl carrier protein] synthase I and II

Identifiers

PMID31581944
PMCPMC6777021
OpenAlexW2979122249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.